Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Absorb GT1 Bioresorbable Vascular Scaffold (BVS) System Post-marketing Surveillance (PMS)

NCT03409731 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT03409731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03409731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Absorb GT1 Bioresorbable Vascular Scaffold (BVS) System Post-marketing Surveillance (PMS)
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
December 13, 2016
Completion date
February 6, 2023
Enrollment
135 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

angina pectoris, coronary artery disease, coronary artery occlusion, ischemic heart disease, myocardial ischemia